This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2012 Mar 13;9(5):258.

doi: 10.1038/nrcardio.2012.36.

Antiplatelet therapy. Intracoronary abciximab during PCI for STEMI

PMID: 22411290
DOI: 10.1038/nrcardio.2012.36

Comment

Antiplatelet therapy. Intracoronary abciximab during PCI for STEMI

Gregory B Lim. Nat Rev Cardiol. 2012.

. 2012 Mar 13;9(5):258.

doi: 10.1038/nrcardio.2012.36.

Author

PMID: 22411290
DOI: 10.1038/nrcardio.2012.36

No abstract available

PubMed Disclaimer

Comment on

Intracoronary versus intravenous bolus abciximab during primary percutaneous coronary intervention in patients with acute ST-elevation myocardial infarction: a randomised trial.
Thiele H, Wöhrle J, Hambrecht R, Rittger H, Birkemeyer R, Lauer B, Neuhaus P, Brosteanu O, Sick P, Wiemer M, Kerber S, Kleinertz K, Eitel I, Desch S, Schuler G. Thiele H, et al. Lancet. 2012 Mar 10;379(9819):923-931. doi: 10.1016/S0140-6736(11)61872-2. Epub 2012 Feb 21. Lancet. 2012. PMID: 22357109 Clinical Trial.

References

1. Lancet. 2012 Mar 10;379(9819):923-931 - PubMed

Publication types

Actions

LinkOut - more resources

Full Text Sources
- Nature Publishing Group
- Ovid Technologies, Inc.
Miscellaneous
- NCI CPTAC Assay Portal